1979
DOI: 10.1016/0013-9351(79)90059-8
|View full text |Cite
|
Sign up to set email alerts
|

Effects of methylmercuric chloride in the presence of cyclic AMP-stimulating agents on glioma and neuroblastoma cells in culture

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1979
1979
1990
1990

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…In the preceding article, we discussed literature reports describing MeHg-induced elevations of both cyclic AMP and Ca2+ in neuroblastoma and synapto-soma1 systems, respectively (Prasad et al, 1979;Komulainen and Bondy, 1987). Activation of second messenger systems such as these would produce increased phosphorylation of a large subset of protein substrates for Ca2+/calmodulin-dependent protein kinase, protein kinase C, and/or cyclic AMP-dependent protein kinase.…”
Section: Discussionmentioning
confidence: 99%
“…In the preceding article, we discussed literature reports describing MeHg-induced elevations of both cyclic AMP and Ca2+ in neuroblastoma and synapto-soma1 systems, respectively (Prasad et al, 1979;Komulainen and Bondy, 1987). Activation of second messenger systems such as these would produce increased phosphorylation of a large subset of protein substrates for Ca2+/calmodulin-dependent protein kinase, protein kinase C, and/or cyclic AMP-dependent protein kinase.…”
Section: Discussionmentioning
confidence: 99%
“…In vitro concentrations of 0.3 µM-1.0 µM CH 3 HgCI produce disturbances in high affinity uptake of certain putative neurotransmitters. Previous shortterm studies have shown [9][10][11][12] that these concentrations of CH 3 HgCl inhibit cell division and increase the intracellular level of cyclic AMP in glioma and NB cells. Long-term treatment of glioma and NB cells with lower concentrations of CH 3 HgCI (0.05-0.2 µM) produces marked alteration in gene expression as evidenced by changes in the amount and phosphorylation of specific proteins [12,13], and reduces the sensitivity of adenylate cyclase to prostaglandin E 1 in glioma cells, but not in NB cells [11].…”
Section: Treatmentmentioning
confidence: 99%